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Abstract:
Background: Adherence to controller therapy in asthma is a major concern during the management of  the disease.
Objective: To determine the adherence rate and identify the predictors of  low adherence to asthma controller therapy.
Methods: A cross-sectional study including asthma patients was conducted from November 1, 2012 to May 31, 2013 in 
4 chest clinics in Cameroon. The adherence to asthma treatment was rated using Morisky Medication Adherence Scale. A 
multivariate logistic regression analysis was performed for the identification of  factors associated with adherence to asthma 
treatment.
Results: Among the 201 asthma patients included, 133 (66.2%) were female. The mean age of  participants was 41.2 years. 
Sixty-one (30.3%) of  the patients did not visit the chest physician during the last year prior to the study. Asthma was well 
controlled in 118 patients (58.7%). The prevalence of  low adherence rate to asthma controller therapy was 44.8% and the 
absence of  any chest specialist visit within the last 12 months was the only factor associated with the low adherence rate to 
asthma treatment (OR 5.57 ; 95% CI 2.84–10.93).
Conclusion: The adherence rate to asthma controller therapy in Cameroon is low and it could be improved if  scheduled 
visits are respected by patients.
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Introduction
Asthma is a heterogeneous disease, characterized by 
variable symptoms of  wheeze, shortness of  breath, 
chest tightness, and/or cough and by variable expirato-
ry flow limitation1. It is one of  the commonest chron-
ic diseases in the world that affects about 300 million 
people2. In Cameroon, the estimated prevalence is 5.7% 
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in adolescents aged 13 to 14 years3. The main goal of  
asthma treatment is to achieve and maintain good con-
trol of  symptoms. This objective needs the acceptance 
of  the diagnosis by the patient and the willingness to 
follow the recommendations provided by the physician. 
Adherence which is defined as the patient’s behaviors 
regarding recommendations from a health care pro-
vider4 is a crucial factor contributing to the control of  
asthma. A recent systematic review showed that good 
adherence to asthma medication is associated with low 
risk of  severe exacerbation5. On the contrary, it has 
been demonstrated that low rate of  adherence to asth-
ma controller therapy is a risk factor for admission to 
the hospital, near-fatal asthma exacerbations, and death 
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from asthma6,7. Furthermore, adherence is also associ-
ated with direct and indirect costs of  care8 and quality 
of  life of  asthma patients9. The introduction of  inhaled 
corticosteroids in recent decades has improved the 
management of  asthma. Corticosteroids are currently 
considered the cornerstone of  maintenance therapy for 
asthma at all levels of  severity in adults and children4. 
Adherence to inhaled corticosteroids is a prerequisite 
for the long term management of  asthma. Less than 
50% of  children are adherent to this treatment while 
in the adult population, the adherence is also low with 
a highly variable range from 30 to 70% depending on 
the area where the studies have been conducted5. In 
Nigeria, Desalu et al. found that 69.3% of  their study 
population had uncontrolled asthma and there was a 
strong association between uncontrolled asthma and 
lack of  adherence to inhaled corticosteroids10. In west-
ern countries, this poor adherence to asthma controller 
therapy has been attributed to safety concerns towards 
the use of  inhaled corticosteroids by patients11. 
In addition, other factors such as gender, age, ethnicity, 
socioeconomic status, psychological problems, fear, and 
misperceptions of  asthma are associated with non ad-
herence to asthma therapy. Besides regular health care 
visits, peak flow variability, and self-perceived severity 
of  disease are correlated with a good adherence to asth-
ma therapy12. The identification of  factors related to the 
adherence to asthma controller therapy is invaluable for 
the effective management of  asthma. Such knowledge 
could help to set up a strategy to improve adherence to 
treatment and could finally lead to the achievement of  
an optimal control of  asthma. Therefore, the aim of  the 
present study was to assess the adherence rates and to 
identify factors associated to low adherence to asthma 
controller medication in a sub-Saharan African setting.
 
Methods
Study design and setting
We conducted a cross-sectional study from 1st Novem-
ber 2012 to 31st May 2013 in the 4 chest specialist con-
sultation clinics in the 2 biggest cities in Cameroon. The 
chest clinics of  two tertiary care hospitals (Jamot Hos-
pital in Yaounde and Douala General Hospital in Doua-
la) and two private chest consultation centers (Centre 
des Maladies Respiratoires and Cabinet de Pneumologie 
d’Akwa) in Douala.
Participants
The study population consisted of  asthma patients aged 
≥ 12 years under an asthma controller therapy and who 
had consulted a chest physician within 2 years prior to 
the study. Subjects were invited through a telephone call 
to participate in the study. These patients had a written 
evidence of  diagnosis of  asthma by a chest physician. 
Patients with cardiac failure, chronic obstructive pul-
monary disease, bronchiectasis, previous tuberculosis, 
lung tumors and other clinically significant respirato-
ry diseases were excluded. The study protocol was re-
viewed and approved by the Cameroon National Ethics 
Committee.
Study procedure
Eligible participants were identified using consultation 
records obtained from the clinics. They were then invit-
ed through a telephone call to participate in the study. 
Upon their arrival at the study site, participants were 
given the information about the study and an oral con-
sent was obtained before the enrolment. Study variables 
were collected using a questionnaire during a face to 
face interview.
Study variables
For each patient included in the study, the sociode-
mographic data was recorded (age, gender, level of  
education,medical insurance status). Medical history 
(hospitalization for an exacerbation, chest physician 
consultation, allergic rhinitis, gastro-oesophageal re-
flux), smoking status, alcohol consumption, body mass 
index (BMI), controller therapy (inhaled corticosteroids 
vs inhaled corticosteroid/long-acting beta-agonists) 
were also recorded. The level of  asthma control was 
assessed during the past 4 weeks by the Asthma Con-
trol Test (ACT)13. An ACT score ≥ 20 indicates well 
controlled asthma, while 16 to 19 indicates partly con-
trolled asthma and ≤ 15 characterizes poorly controlled 
asthma.
Adherence to asthma medication was assessed using 
the eight-item Morisky Medication Adherence Scale 
(MMAS-8)14,15. This patient-report measurement of  
treatment adherence has a maximum score of  8 points 
and is classified in 3 levels: low adherence (score < 6 
points), medium adherence (score between 6 and 7 
points) and high adherence (score = 8 points).
Data analysis
Data was analyzed using SPSS version 20. Descriptive 
statistics were used to report the baseline characteristics 
of  the participants. Bivariate associations between treat-
ment adherence and patient characteristics were tested 
using chi-square tests. During this analysis, asthma was 
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considered controlled for an ACT score ≥ 20 and un-
controlled for a score < 20. As dependant variable, low 
adherence category was compared with medium/high 
adherence category. Variables with a p-value less than 
0.20 in the bivariate analysis were included in a multi-
variate logistic regression analysis for the examination 
of  factors independently associated with the medica-
tion adherence. The odds ratio (OR) and its 95% con-
fidence interval (CI) were determined for each variable. 
A p-value less than 0.05 was considered to be statistical 
significant.
Results
Among the 1063 patients registered in the 4 clinics, 466 
were contacted and 243 came for the survey. Forty two 
of  them were excluded because they were not on any 
controller medication. A total of  201 asthma patients 
were finally included in the study. Among these, 133 
(66.2%) were female. The mean age of  participants was 
41.16 ± 18.9 years (range 12 – 87). The percentage of  
those covered by a medical insurance was 28.4% (57 
participants) and 61(30.3%) of  the participants had not 
attended a chest physician clinic for the last 12 months 
prior to the study. The mean BMI was 27 ± 6 kg/m2 
(range 13.51 – 45.45). Asthma was well controlled in 
118 patients (58.7%), partly controlled in 45 (22.4%) 
and poorly controlled 38 (18.9%). The mean MMAS-8 
score was 5.52 ± 2.02 while 90 patients had a low rate 
of  adherence to asthma controller medication, giving 
a prevalence of  44.8% (95% CI; 37.8 – 51.7). The ad-
herence was medium for 73 (36.3%) and high for 38 
(18.9%) patients. The other characteristics of  the gen-
eral population are shown in table 1.
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Table 1: Baseline characteristics of participants (N=201) 
 







   < 50 years 














   Male 













Level of education 
   ≤ Primary school 














   Yes 














   < 12 months 













Chest physician visit 
   ≤ 12 months 














   ≤ 8 years 














   Yes 













Obesity (BMI ≥ 30 kg/m2) 
   No 














   Yes 














   Yes 













Asthma controller therapy 
   ICSa 














   Well controlled 
   Partly uncontrolled 

















      aICS: Inhaled corticosteroid              bLABA: long-acting beta-agonists 
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The bivariate analysis (Table 2) shows that not visiting 
the chest specialist was significantly associated with low 
adherence to asthma medication. 
Though not statistically significant, participants aged 
less than 40 years and those with at least a secondary 
education were more prone to have a low adherence 
rate to asthma treatment.
Table 2. Bivariate analysis of factors associated with adherence to asthma  
controller therapy (N=201) 
 
Variables Medication adherence P value 
Low adherence Medium/High   
Age 
   < 40 years 










   Male 










   ≥ Secondary school 










   Yes 









Ever Hospitalized for 
asthma 
   Yes 










   ≥ 12 months 









Chest physician visit 
   > 12 months 
   ≤ 12 months 
  







Duration of asthma 
   ≤ 8 years 
   > 8 years 
  








   Yes 
   No 
  
16 (41) 







  Yes (ACT ≥ 20) 









Asthma controller therapy 
   ICS 
   ICS + LABA 
  
22 (44) 











In the multivariate model (Table 3), the only variable in-
dependently associated with the low rate of  medication 
adherence was the absence of  chest physician consulta-
tion during the last 12 months prior to the study (OR 
5.57; 95% CI 2.84 – 10.93).
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Table 3. Multivariate analysis of factors associated with adherence to asthma controller 
therapy (N=201) 
 
Variables Medication adherence aORa (95% CI) P value 
Low adherence Medium/High 
Age 
   < 40 years 












   Male 








1.21 (0.64 – 2.31) 
  
0.54 
Level of education 
   = Secondary school 








1.7 (0.70 – 4.07) 
  
0.23 
Chest physician visit 
   > 12 months 








5.57 (2.84 – 10.93) 
  
< 0.001 
aaOR: Adjusted odds ratio 
  
African Health Sciences Vol 16 Issue 1, March 2016
Discussion
This study was carried out to assess controller therapy 
adherence among asthma patients. Adherence to treat-
ment is considered the major factor influencing the con-
trol of  asthma16,17. In the present study, we found a low 
adherence to treatment among our patients and only 
18.9% of  the sample population had high adherence 
rate. The only factor independently associated with low 
adherence to asthma controller therapy was not hav-
ing visited the chest specialist during the previous 12 
months. Age older than 40 years was at the border of  
statistical significance.
This result shows that a substantial proportion of  asth-
ma patients do not adhere to the asthma controller 
therapy and this finding is consistent with some pre-
vious studies in which the Morisky scale was used to 
assess adherence to asthma medication. In fact, a study 
conducted in four Asian countries among 1054 asthma 
patients also found an adherence rate of  18.9%18. An-
other study involving 1410 patients with persistent asth-
ma showed that 20.7% of  them were highly adherent to 
inhaled corticosteroids therapy19. These rates are con-
siderably lower than the 60% reported by Demoly et 
al in a community-based survey that involved five Eu-
ropean countries20. In a tertiary care setting in Nigeria, 
Desalu et al. found 80.4% of  low adherence to inhaled 
corticosteroid reported by patients10. This proportion is 
higher than our finding probably because the methods 
used to define low adherence were not similar in the 
two studies.
The present study also showed that no visit of  the asth-
ma patients to a chest physician in the last 12 month 
prior to the study was the only independent predictor 
of  treatment adherence. Similar results were found 
by Corsico et al in European Community Respiratory 
Health Survey study of  971 subjects with asthma21. In 
fact, it has been demonstrated that regular follow up 
consultations with clinicians reinforce the partnership 
between patients and healthcare workers with a subse-
quent positive effect on the medication adherence22-24.
We found that asthma patients older than 40 years had a 
better adherence to asthma treatment. This finding cor-
roborates the results of  previous studies showing that 
the adherence to asthma controller therapy increases 
with age25,26. On the contrary, Apter et al did not ob-
serve any relationship between age and adherence to 
asthma controller mediation in a similar study in the 
United States27. Interestingly, in another study involv-
ing elderly asthma patients aged 65 years and above, the 
treatment adherence was very low28. These conflicting 
results are probably due to the differences in the meth-
ods used to assess adherence in these studies. Future 
research using a better method of  assessment of  medi-
cation adherence such as electronic monitor devices29,30 
is needed to conclude on any relationship between age 
and adherence to asthma controller therapy.
 
Variables Medication adherence aORa (95% CI) P value 
Low adherence Medium/High 
Age 
   < 40 years 












   Male 
   Female 
  
35 ( 1.5%) 
55 (41.4%) 
  
33 4 .5 ) 
78 (58.6%) 
  
1.21 (0.64 – 2.31) 
  
0.54 
Level of education 
   ≥ Secondary school 








1.7 (0.70 – 4.07) 
  
0.23 
Chest physician visit 
   > 12 months 








5.57 (2.84 – 10.93) 
  
< 0.001 
aaOR: Adjusted odds ratio 
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Although the proportion of  patients with low adher-
ence was greater among patients with uncontrolled 
asthma (84.2%) than in patients with controlled asthma 
(42.4%), the difference was not statistically significant. 
The absence of  correlation between this two variables 
could be explained by the fact that some patients may 
have misestimated their asthma control and adherence 
to medication.
We did not find any relationship between sex, level of  
education, possession of  medical insurance, duration 
of  asthma, hospitalization for asthma and adherence to 
asthma controller medication. Conflicting results have 
been reported concerning the effect of  sex on adher-
ence to asthma medication21,25,31 as well as that of  edu-
cation level and medical insurance coverage12,29,30.
This study which is among the first to assess adher-
ence to asthma medication in sub-Saharan Africa has 
some limitations. Firstly, although the Morisky scale has 
been validated in the measurement of  treatment ad-
herence, it is a self-reported method and patients may 
have wrongly estimated their adherence to asthma treat-
ment. Secondly, other characteristics such as inhalation 
technique, the socioeconomic status and knowledge of  
asthma were not investigated as factors associated with 
asthma medication adherence. The small size of  the 
sample may have also underpowered the study.
Conclusion
The adherence rate to asthma controller therapy in 
chest clinics in Cameroon is very low. Less frequent 
visits to the chest physician is the main contributor to 
this low adherence. These findings constitute additional 
evidence that there is considerable need for improve-
ment in treatment adherence among sub-Saharan Afri-
can asthma patients. Education of  patients on the im-
portance of  maintenance therapy during scheduled visit 
would surely contribute to the increase of  adherence 
rate to asthma treatment.
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